Technologies using antiparasitic drugs to treat Chagas disease
DOI:
https://doi.org/10.29397/reciis.v10i1.1075Keywords:
Chagas disease, Trypanosoma cruzi, Antiparasitic Agents, Patents, Medicines.Abstract
With increasing diagnostic Chagas disease, it is necessary to develop drugs that have a greater effect against parasites. This article aims to present a technological mapping of patent documents related to technologies employing antiparasitic drugs to treat Chagas disease, through the patent database United States Patent and Trademark Office - USPTO. 117 patents were analyzed, and the first patent was filed on that basis in 1976. The results show that studies of the treatment of Chagas disease through antiparasitic drugs are in development, focused on preventing the disease, and most of them are subsidized by private initiatives. There is little interest from the pharmaceutical industry to develop new drugs for treatment and universities have no incentive to develop research in this area.
Downloads
Published
How to Cite
Issue
Section
License
Author’s rights: The author retains unrestricted rights over his work.
Rights to reuse: Reciis adopts the Creative Commons License, CC BY-NC non-commercial attribution according to the Policy on Open Access to Knowledge by Oswaldo Cruz Foundation. With this license, access, download, copy, print, share, reuse, and distribution of articles is allowed, provided that it is for non-commercial use and with source citation, granting proper authorship credits and reference to Reciis. In such cases, no permission is required from the authors or editors.
Rights of authors’s deposit / self-archiving: The authors are encouraged to deposit the published version, along with the link of their article in Reciis, in institutional repositories.